Summary
The National Institutes of Health (NIH) is soliciting applications for institutional training programs designed to advance translational research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD). This is a T32 mechanism award, meaning funds are provided to institutions to support the training of predoctoral and/or postdoctoral researchers. Clinical trials are explicitly not allowed under this funding opportunity. The program aims to build a pipeline of skilled investigators capable of conducting translational AD/ADRD research.